VVOS - Vivos Therapeutics Inc. (VVOS) Q4 2023 Earnings Call Transcript
2024-03-28 23:10:02 ET
Vivos Therapeutics, Inc. (VVOS)
Q4 2023 Earnings Conference Call
March 28, 2024 05:00 PM ET
Company Participants
Julie Gannon - Investor Relations Officer
Kirk Huntsman - Chairman & Chief Executive Officer
Brad Amman - Chief Financial Officer
Conference Call Participants
Scott Henry - AGP
Lucas Ward - Ascendiant
Presentation
Operator
Good day, everyone, and welcome to Vivos Therapeutics Fourth Quarter and Full Year 2023 Conference Call. At this time, participants are in a listen-only mode. A question-and-answer session will follow management's remarks. This conference is being recorded, and a replay of today's call will be available on the Investor Relations section of Vivos' website and will remain posted there for the next 30 days.
I will now hand over the call to Julie Gannon, Vivos' Investor Relations Officer for introductions and reading of the safe harbor statement. Please go ahead.
Julie Gannon
Thank you, operator. Hello, everyone, and welcome to our conference call. A copy of our earnings press release is available on the Investor Relations section of our website at www.vivos.com.
With us on today's call are Kirk Huntsman, Vivos' Chairman and Chief Executive Officer; and Brad Amman, Chief Financial Officer.
Today, we'll review the highlights and financial results for the fourth quarter and full year 2023 as well as more recent developments and Vivos plans for 2024. Following these formal remarks, we will be happy to take questions....
Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript